» Recombinant human tissue factor

HEMOSTASIS COAGULATION RESEARCH PLASMA DERIVED PROTEINS TISSUE FACTOR

Recombinant human tissue factor

Formulation: lyophilized protein in a 10 mM Tris-HCl buffer, 150 mM NaCl, 0.01% CHAPS, pH 8, 200 mM Mannitol.

Whole recombinant human FT.
Animated acids 1 to 263 including the extracellular, transmembrane, cytoplasmic domains.
MW(Da) : 35 000 (38 kDa band under reduced conditions)

Reference	11-4500
Presentation	Vial
Format	25 μg
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
11-4500	Vial	25 μg

Price list, safety data sheets and notices are accessible to our registered customers.

Tissue factor (FT) is a transmembrane glycoprotein which is primarily responsible for activating coagulation cascades in the event of a vascular breach.
The binding of FVII to its receptor, expressed by the cells of the subendothelium exposed by the lesion, allows its very rapid activation by traces of FXa, circulating in trace amounts in vivo.
The FT-FVIIa complex then causes the activation of FIX and FX and the formation of thrombin.

Upon relipidation, this product will promote clotting in a two-stage prothrombin time test.
Add 1.0 mL of filtered deionized or sterile water to generate a 25 μg/mL.
Store lyophilized vials at +2/+8°C. Store reconstituted protein in aliquots frozen at -20°C or colder, avoid freeze-thaw cycles.

The lyophilized presentation allows greater stability until the expiration date.

Screw capped clear glass vials of 25 μg of protein lyophilized from 10 mM TRIS HCI, 150 mM NaCI, 0.01% CHAPS, pH 8.0, with 200 mM mannitol.

Recombinant tissue Factor
Relipidated recombinant human tissue Factor protein

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH PLASMA DERIVED PROTEINS TISSUE FACTOR